Pulmonary pleomorphic carcinoma – pro
Pulmonary pleomorphic carcinoma (PC) is a rare malignant tumor of the lung and its incidence has been reported to range from 0.1% to 0.4% of all lung cancer. PC has a more aggressive clinical course and a worse outcome than other nonsmall cell lung cancer (NSCLC).
Very littlwe is known about this rare cancer, only published in the format of case reports. however, they indicate that surgical treatmetn s effective and that advanced pulmonary pleomorphic carcinoma was found to respond poorly to the platinum- and nonplatinum-based chemotherapy regimens.
Kim TH, Kim SJ, Ryu YH, et al. Pleomorphic carcinoma of lung: comparison of CT features and pathologic findings. Radiology 2004;232:554–9. [PubMed]
Raveglia F, Mezzetti M, Panigalli T, et al. Personal experience in surgical management of pulmonary pleomorphic carcinoma. Ann Thorac Surg 2004;78:1742–7. [PubMed]
Bae HM, Min HS, Lee SH, et al. Palliative chemotherapy for pulmonary pleomorphic carcinoma. Lung Cancer 2007;58:112–5.
Zhang X, Wang Y, Zhao L, Jing H, Sang S, Du J. Pulmonary pleomorphic carcinoma: A case report and review of the literature. Medicine (Baltimore). 2017;96(29):e7465.